Current FY Submissions

The following are a list of recent fiscal year grant submissions the Center for Women's Health Research. Learn more about our services and obtain assistance with your own submission.

FY2018

July 1, 2017 through June 30, 2018

Ovarian Cancer Clinical Follow-up

Victoria Bae-Jump, MD, PhD; Division of Gynecologic Oncology
R01 Subcontract to University of Virginia
Sponsor: National Institutes of Health (NIH)
Submitted: July 22, 2017

 

 


FY2017

July 1, 2016 through June 30, 2017

Pulmonary Complications in a Birth Cohort after a Randomized Trial of Exposure to Antenatal Corticosteroids: the ALPS Follow-Up Study

John Thorp, Jr, MD; Division of Women's Primary Healthcare
R01 Subcontract to George Washington University
Sponsor: National Institutes of Health (NIH)
Submitted: July 11, 2016

 

Topical Therapies for Cervical Intraepithelial Neoplasia (CIN) 2-3

Lisa Rahangdale, MD, MPH; Division of Women's Primary Healthcare
R21 Submission
Sponsor: NIH
Submitted: July 13, 2016

 

Topical Therapies for treatment of CIN 2-3

Lisa Rahangdale, MD, MPH; Division of Women's Primary Healthcare
Subcontract to University of Arizona
Sponsor: National Institutes of Health (NIH)
Submitted: September 6, 2016

 

Understanding and Influencing Pregnancy Spacing and Postpartum Contraceptive Use: The Development and Testing of a Web-Based and Text Messaging Intervention

John Thorp, Jr., MD; Division of Women's Primary Healthcare
Subcontract to Research Triangle Institute (RTI International)
Sponsor: DHHS Health Resources and Services Administration (HRSA)
Submitted: September 9, 2016

 

BCL6 and SIRT1 as a Primary Cause of Progesterone Resistance and Endometrial Receptivity Defects in Women

Steve Young, MD, PhD; Division of Reproductive Endocrinology and Infertility
New Submission
Sponsor: European Society of Human Reproduction and Embryology (ESHRE)
Submitted: September 9, 2016

 

Prenatal Preparation: Actions and Results

Neeta Vora, MD; Division of Maternal-Fetal Medicine
R01 Subcontract to the University of California, San Francisco
Sponsor: National Institutes of Health (NIH)
Submitted: September 15, 2016

 

Safe Prevention of the Primary Cesarean: High- vs Low-dose Oxytocin Regimens for Labor Stimulation

Alison Stuebe, MD, PhD; Division of Maternal-Fetal Medicine
R01 Subcontract to University of Alabama at Birmingham
Sponsor: National Institutes of Health (NIH)
Submitted: September 20, 2016

 

Non-destructive isolation of trophoblast subtypes

Kim Boggess, MD; Division of Maternal-Fetal Medicine
R21 Subcontract to NC State University
Sponsor: National Institutes of Health (NIH)
Submitted: September 30, 2016

 

MOMPOD Plus

Kim Boggess, MD; Division of Maternal-Fetal Medicine
Collaborative Co-Support Award
Sponsor: American Diabetes Association (ADA)
Submitted: September 30, 2016

 

Pharmacogenomics of Preterm Birth

Tracey Manuck, MD; Division of Maternal-Fetal Medicine
R01 Submission
Sponsor: National Institutes of Health (NIH)
Submitted: October 5, 2016

 

Future care planning for families affected by parental advanced cancer

Eliza Park, MD; Department of Psychiatry
K07 Submission
Sponsor: National Institutes of Health (NIH)
Submitted: October 12, 2016

 

Phase II Study of Nicotinamide Supplementation in Severe Preeclampsia

Kim Boggess, MD; Division of Maternal-Fetal Medicine
R03 Submission
Sponsor: National Institutes of Health (NIH)
Submitted: October 16, 2016

 

Social adversities, epigenetics, and the obesity epidemic

John Thorp, Jr., MD; Division of Women's Primary Healthcare
R01 Subcontract to North Carolina State University
Sponsor: National Institutes of Health (NIH)
Submitted: November 3, 2016

 

A comprehensive intervention to treat emerging drug-using populations in India

Hendree Jones, PhD; Director of UNC Horizons
R01 Re-submission
Sponsor: National Institutes of Health (NIH)
Submitted: November 5, 2016

 

A randomized controlled trial comparing buprenorphine+naloxone to buprenorphine in pregnant women with opioid use disorder Submitted

Hendree Jones, PhD; Director of UNC Horizons
R01 Submission
Sponsor: National Institutes of Health (NIH)
Submitted: November 5, 2016

 

Psychosocial stressors, epigenetics, and Preterm Birth

Tracy Manuck, MD; Division of Maternal-Fetal Medicine
R01 Submission
Sponsor: National Institutes of Health (NIH)
Submitted: November 15, 2016

 

Inter-relationship between microbiota diversity, obesity and race in Endometrial Cancer

Victoria Bae-Jump, MD, PhD; Division of Gynecologic Oncology
R21 Submission
Sponsor: National Institutes of Health (NIH)
Submitted: November 17, 2016

 

Safe Prevention of the Primary Cesarean: High- vs Low-dose Oxytocin Regimens for Labor Stimulation

Alison Stuebe, MD, PhD; Division of Maternal-Fetal Medicine
Subcontract to the University of Alabama at Birmingham
Sponsor: Patient-Centered Outcomes Research Institute (PCORI)
Submitted: December 6, 2016

 

An expert curation panel to establish clinical relevance of genomic variants associated with severe and lethal fetal phenotypes

Neeta Vora, MD; Division of Maternal-Fetal Medicine
U24 Subcontract to Baylor College
Sponsor: NIH
Submitted: December 21, 2016

 

SBIR: Podocyte Capture

John Thorp, Jr., MD; Division of Women's Primary Healthcare
R43/R44 Submission
Sponsor: NIH
Submitted: December 22, 2016

 

A Randomized Controlled Trial of Pravastatin for the Prevention of Preeclampsia in High Risk Women

John Thorp, Jr., MD; Division of Women's Primary Healthcare
U24 Subcontract to George Washington University
Sponsor: Patient-Centered Outcomes Research Institute (PCORI)
Submitted: Jan 13, 2017

 

A Decision Aid to Improve Pregnant Couples' Decision Making about Expanded Carrier Screening

Neeta Vora, MD; Division of Maternal-Fetal Medicine
R01 Submission
Sponsor: NIH
Submitted: Jan 17, 2017

 

Obesity-driven Metabolic and Molecular Biomarkers of Metformin Response in Endometrial Cancer

Victoria Bae-Jump, MD, PhD; Division of Gynecologic Oncology
R01 Submission
Sponsor: NIH
Submitted: Jan 26, 2017

 

A New Era of Genomics for Fetal Diagnosis

Neeta Vora, MD; Division of Maternal-Fetal Medicine
CRTG Travel Grant
Sponsor: Burroughs Wellcome Fund
Submitted: Jan 26, 2017

 

Mood, mother, and child: The psychobiology of dyadic resilience

Alison Stuebe, MD, PhD; Division of Maternal-Fetal Medicine
R01 Submission
Sponsor: NIH
Submitted: Jan 27, 2017

 

Administrative Supplement: Medical Optimization and Management of Pregnancies with Overt Type 2 Diabetes (MOMPOD)

Kim Boggess, MD; Division of Maternal-Fetal Medicine
Administrative Supplement
Sponsor: NIH/ORWH
Submitted: Feb 08, 2017

 

Euglycemia after antenatal late preterm steroids, the E-ALPS study

Ashley Battarbee, MD; Division of Maternal-Fetal Medicine
R21 Submission
Sponsor: NIH
Submitted: Feb 16, 2017

 

Maternal Obesity, Epigenetics and Childhood Obesity

John Thorp, Jr., MD; Division of Women's Primary Healthcare
R01 Submission, Subcontract to North Carolina State University
Sponsor: NIH
Submitted: March 21, 2017

 

Collaborative Research for Pathophysiology of Endometriosis

Steve Young, MD, PhD; Division of Reproductive Endocrinology and Infertility
R01 Submission, Subcontract to Michigan State University
Sponsor: NIH
Submitted: March 21, 2017

 

Engineered split-enzyme biosensors for non-invasive and rapid quantification of placental proteins

Kim Boggess, MD; Division of Maternal-Fetal Medicine
R21 Submission, Subcontract to North Carolina State University
Sponsor: NIH
Submitted: March 21, 2017

 

Vestibulodynia Pain Pathways

Elizabeth Geller, MD; Division of Urogynecology and Reconstructive Pelvic Surgery
R01 Submission, Subcontract to Duke University
Sponsor: NIH
Submitted: March 28, 2017

 

Metabolic and Molecular Biomarkers of Metformin Response in Obesity-driven Endometrial Cancer

Victoria Bae-Jump, MD, PhD; Division of Gynecologic Oncology
Foundation Grant
Sponsor: V Foundation
Submitted: May 2, 2017

 

Inflammatory mediators of endometrial progesterone resistance

Steve Young, MD, PhD; Division of Reproductive Endocrinology and Infertility
R01 Subcontract to Greenville Health Systems
Sponsor: National Institutes of Health (NIH)
Submitted: May 30, 2017

 

Obesity-driven Metabolic and Molecular Biomarkers of Metformin Response in Endometrial Cancer

Victoria Bae-Jump, MD, PhD; Division of Gynecologic Oncology
R01 Submission
Sponsor: National Institutes of Health (NIH)
Submitted: June 5, 2017

 

HMRI Subk Evaluation of the effect of environmental factors and consequent pregnancies on uterine contractility

Tracy Manuck, MD; Division of Maternal-Fetal Medicine
R21 Submission
Sponsor: National Institutes of Health (NIH)
Submitted: June 7, 2017

 

Inter-relationship between microbiota diversity, obesity and race in endometrial cancer

Victoria Bae-Jump, MD, PhD; Division of Gynecologic Oncology
R21 Resubmission
Sponsor: National Institutes of Health (NIH)
Submitted: June 19, 2017

 

The Pharmacoepigenomics of Recurrent Preterm Birth in Non-Hispanic Black Women

Tracy Manuck, MD; Division of Maternal-Fetal Medicine
R01 Resubmission
Sponsor: National Institutes of Health (NIH)
Submitted: June 23, 2017

 

Windows of Opportunity Study of Atezolizumab in Early Stage, High Grand Obesity-driven Endometrial Cancer

Victoria Bae-Jump, MD, PhD; Division of Gynecologic Oncology
R01 Subcontract to University of Alabama at Birmingham
Sponsor: American Association for Cancer Research (AACR)
Submitted: June 26, 2017

 

A Stepped Wedge Implementation Study of Shared Decision Making for VBAC with an Interactive Decision Aid

Victoria Bae-Jump, MD, PhD; Division of Gynecologic Oncology
SU2C Catalyst™ Research Grant
Sponsor: National Institutes of Health (NIH)
Submitted: June 27, 2017